Leukocyte alterations do not account for hepatitis induced by endotoxin or TNFα in galactosamine-sensitized mice

This publication has 20 references indexed in Scilit:

• Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice
  Biochemical Pharmacology, 1989
• Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
  The Journal of Experimental Medicine, 1987
• A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
  Journal of Immunological Methods, 1986
• Tumor necrosis factor-induced alterations in circulating leukocyte populations
  Biochemical and Biophysical Research Communications, 1986
• Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.
  Journal of Clinical Investigation, 1986
• Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.
  The Journal of Experimental Medicine, 1985
• Enhanced phospholipase A2 activity in rat plasma, liver, and intestinal mucosa following endotoxin treatment: A possible explanation for the protective effect of indomethacin in endotoxic shock
  Metabolism, 1985
• The Effect of Endotoxin on Circulating Lymphocytes in Normal Man
  British Journal of Haematology, 1977
• Significance of leukocytes in endotoxic shock
  Experimental and Molecular Pathology, 1975
• QUANTITATIVE STUDIES OF HUMAN LEUKOCYTIC AND FEBRILE RESPONSE TO SINGLE AND REPEATED DOSES OF PURIFIED BACTERIAL ENDOTOXIN*
  Journal of Clinical Investigation, 1962